Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank93
3Y CAGR+3.1%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

3Y CAGR
+3.1%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20259.85%-35.5%
202415.28%+125.8%
2023-59.26%-758.7%
20229.00%+100.8%
2021-1140.99%-316.6%
2020-273.87%-
20190.00%+100.0%
2018-563700.00%-26196.7%
2017-2143.61%+58.1%
2016-5117.29%-